Treatment of afferent loop syndrome using fluoroscopic-guided nasointestinal tube placement: Two case reports.

paythelady.612 shared this article with you from Inoreader Treatment of afferent loop syndrome using fluoroscopic-guided nasointestinal tube placement: Two case reports. Μέσω pubmed: "world j clin cases"... Related Articles Treatment of afferent loop syndrome using fluoroscopic-guided nasointestinal tube placement: Two case reports. World J Clin Cases. 2020 Nov 06;8(21):5353-5360 Authors: Hu HT, Ma FH, Wu ZM, Qi XH, Zhong YX, Xie YB, Tian YT Abstract BACKGROUND: Afferent loop syndrome (ALS) is a rare mechanical complication that occurs after reconstruction of the stomach or esophagus to the jejunum, such as Billroth II gastrojejunostomy, Roux-en-Y gastrojejunostomy, or Roux-en-Y esophagoje-junostomy. Traditionally, an operation is the first choice for benign causes. However, for patients in poor physical condition who experience ALS soon after R0 resection, the type of treatment remains controversial. Here, we present an efficient conservative method to treat ALS. CASE SUMMARY: Case 1 was a 69-year-old male patient who underwent total gastrectomy with Roux-en-Y jejunojejunostomy. On postoperative day (POD) 10 he developed symptoms of ALS that persisted and increased over 1 wk. Case 2 was a 59-year-old male patient who underwent distal gastrectomy with Billroth II gastrojejunostomy. On postoperative day POD 9 he developed symptoms of ALS that persisted for 2 wk. Both patients underwent fluoroscopic-guided nasointestinal tube placement with maintenance of continuous negative pressure suction. Approximately 20 d after the procedure, both patients had recovered well and were discharged from hospital after removal of the tube. At 3-mo follow-up, there were no signs of ALS in these two patients. CONCLUSION: This is the first report of treating postoperative ALS by fluoroscopic-guided nasointestinal tube placement. Our cases demonstrate that this procedure is an effective and safe method to treat ALS that relieves patients' symptoms and avoids complications caused by other invasive procedures. PMID: 33269270 [PubMed] View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.